Cargando…

Palliative care and healthcare utilization among deceased metastatic lung cancer patients in U.S. hospitals

OBJECTIVE: The benefits of palliative care for cancer patients were well developed; however, the characteristics of receiving palliative care and the utilization patterns among lung cancer patients have not been explored using a large-scale representative population-based sample. METHODS: The Nation...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Jongwha, Han, Kyu-Tae, Medina, Mar, Kim, Sun Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327255/
https://www.ncbi.nlm.nih.gov/pubmed/35897031
http://dx.doi.org/10.1186/s12904-022-01026-y
_version_ 1784757470830264320
author Chang, Jongwha
Han, Kyu-Tae
Medina, Mar
Kim, Sun Jung
author_facet Chang, Jongwha
Han, Kyu-Tae
Medina, Mar
Kim, Sun Jung
author_sort Chang, Jongwha
collection PubMed
description OBJECTIVE: The benefits of palliative care for cancer patients were well developed; however, the characteristics of receiving palliative care and the utilization patterns among lung cancer patients have not been explored using a large-scale representative population-based sample. METHODS: The National Inpatient Sample of the United States was used to identify deceased metastatic lung cancer patients (n = 5,068, weighted n = 25,121) from 2010 to 2014. We examined the characteristics of receiving palliative care use and the association between palliative care and healthcare utilization, measured by discounted hospital charges and LOS (length of stay). The multivariate survey logistic regression model (to identify predictors for receipts of palliative care) and the survey linear regression model (to measure how palliative care is associated with healthcare utilization) were used. RESULTS: Among 25,121 patients, 50.1% had palliative care during the study period. Survey logistic results showed that patients with higher household income were more likely to receive palliative care than those in lower-income groups. In addition, during hospitalization, receiving palliative care was associated with11.2% lower LOS and 28.4% lower discounted total charges than the non-receiving group. CONCLUSION: Clinical evidence demonstrates the benefits of palliative care as it is associated with efficient end-of-life healthcare utilization. Health policymakers must become aware of the characteristics of receiving the care and the importance of limited healthcare resource allocation as palliative care continues to grow in cancer treatment.
format Online
Article
Text
id pubmed-9327255
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93272552022-07-28 Palliative care and healthcare utilization among deceased metastatic lung cancer patients in U.S. hospitals Chang, Jongwha Han, Kyu-Tae Medina, Mar Kim, Sun Jung BMC Palliat Care Research OBJECTIVE: The benefits of palliative care for cancer patients were well developed; however, the characteristics of receiving palliative care and the utilization patterns among lung cancer patients have not been explored using a large-scale representative population-based sample. METHODS: The National Inpatient Sample of the United States was used to identify deceased metastatic lung cancer patients (n = 5,068, weighted n = 25,121) from 2010 to 2014. We examined the characteristics of receiving palliative care use and the association between palliative care and healthcare utilization, measured by discounted hospital charges and LOS (length of stay). The multivariate survey logistic regression model (to identify predictors for receipts of palliative care) and the survey linear regression model (to measure how palliative care is associated with healthcare utilization) were used. RESULTS: Among 25,121 patients, 50.1% had palliative care during the study period. Survey logistic results showed that patients with higher household income were more likely to receive palliative care than those in lower-income groups. In addition, during hospitalization, receiving palliative care was associated with11.2% lower LOS and 28.4% lower discounted total charges than the non-receiving group. CONCLUSION: Clinical evidence demonstrates the benefits of palliative care as it is associated with efficient end-of-life healthcare utilization. Health policymakers must become aware of the characteristics of receiving the care and the importance of limited healthcare resource allocation as palliative care continues to grow in cancer treatment. BioMed Central 2022-07-27 /pmc/articles/PMC9327255/ /pubmed/35897031 http://dx.doi.org/10.1186/s12904-022-01026-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chang, Jongwha
Han, Kyu-Tae
Medina, Mar
Kim, Sun Jung
Palliative care and healthcare utilization among deceased metastatic lung cancer patients in U.S. hospitals
title Palliative care and healthcare utilization among deceased metastatic lung cancer patients in U.S. hospitals
title_full Palliative care and healthcare utilization among deceased metastatic lung cancer patients in U.S. hospitals
title_fullStr Palliative care and healthcare utilization among deceased metastatic lung cancer patients in U.S. hospitals
title_full_unstemmed Palliative care and healthcare utilization among deceased metastatic lung cancer patients in U.S. hospitals
title_short Palliative care and healthcare utilization among deceased metastatic lung cancer patients in U.S. hospitals
title_sort palliative care and healthcare utilization among deceased metastatic lung cancer patients in u.s. hospitals
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327255/
https://www.ncbi.nlm.nih.gov/pubmed/35897031
http://dx.doi.org/10.1186/s12904-022-01026-y
work_keys_str_mv AT changjongwha palliativecareandhealthcareutilizationamongdeceasedmetastaticlungcancerpatientsinushospitals
AT hankyutae palliativecareandhealthcareutilizationamongdeceasedmetastaticlungcancerpatientsinushospitals
AT medinamar palliativecareandhealthcareutilizationamongdeceasedmetastaticlungcancerpatientsinushospitals
AT kimsunjung palliativecareandhealthcareutilizationamongdeceasedmetastaticlungcancerpatientsinushospitals